跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Philippines FDA
/
Ampimax
Approved
STANDARD
Ampimax
Bilim Ilac Sanayi Ve Ticaret A.S
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
f5f44c502ecf06b1
Company
Bilim Ilac Sanayi Ve Ticaret A.S
Type
Standard
Approval Details
Approval Id
f5f44c502ecf06b1
Drug Approval Philippines Name
Ampimax
Product Name
Ampimax
Registration Number
DRP-4190
Brand Name
Ampimax
Generic Name
Sultamicillin (as tosilate dihydrate)
Dosage Form
Film Coated Tablet
Dosage Strength
750 mg
Manufacturer
Bilim Ilac Sanayi Ve Ticaret A.S
Importer
UNILAB, Inc.
Distributor
UNILAB, Inc.
Issuance Date
25 January 2023
Expiry Date
28 January 2028
Pharmacologic Category
Antibacterial (Penicillin/Beta-lactamase Inhibitor)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
f5f44c502ecf06b1
Type
Standard
Back to Philippines FDA Approvals
Ampimax - Philippines FDA Drug Approval Details